En­her­tu strikes again with a PhI­II suc­cess in an­oth­er breast can­cer pop­u­la­tion

An­oth­er sum­mer day, an­oth­er En­her­tu up­date.

The As­traZeneca-Dai­ichi Sankyo an­ti­body-drug con­ju­gate has passed an­oth­er tri­al, this time a Phase III tri­al test­ing the can­cer drug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER